• Je něco špatně v tomto záznamu ?

Inhibition of gap-junctional intercellular communication and activation of mitogen-activated protein kinases by cyanobacterial extracts--indications of novel tumor-promoting cyanotoxins?

L. Blaha, P. Babica, K. Hilscherova, B.L. Upham

. 2010 ; 55 (1) : 126-134.

Jazyk angličtina Země Velká Británie

Typ dokumentu srovnávací studie, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12009173

Toxicity and liver tumor promotion of cyanotoxins microcystins have been extensively studied. However, recent studies document that other metabolites present in the complex cyanobacterial water blooms may also have adverse health effects. In this study we used rat liver epithelial stem-like cells (WB-F344) to examine the effects of cyanobacterial extracts on two established markers of tumor promotion, inhibition of gap-junctional intercellular communication (GJIC) and activation of mitogen-activated protein kinases (MAPKs) - ERK1/2. Extracts of cyanobacteria (laboratory cultures of Microcystis aeruginosa and Aphanizomenon flos-aquae and water blooms dominated by these species) inhibited GJIC and activated MAPKs in a dose-dependent manner (effective concentrations ranging 0.5-5mgd.w./mL). Effects were independent of the microcystin content and the strongest responses were elicited by the extracts of Aphanizomenon sp. Neither pure microcystin-LR nor cylindrospermopsin inhibited GJIC or activated MAPKs. Modulations of GJIC and MAPKs appeared to be specific to cyanobacterial extracts since extracts from green alga Chlamydomonas reinhardtii, heterotrophic bacterium Klebsiella terrigena, and isolated bacterial lipopolysaccharides had no comparable effects. Our study provides the first evidence on the existence of unknown cyanobacterial toxic metabolites that affect in vitro biomarkers of tumor promotion, i.e. inhibition of GJIC and activation of MAPKs.

000      
03848naa a2200589 a 4500
001      
bmc12009173
003      
CZ-PrNML
005      
20121126122036.0
008      
120319s2010 xxk eng||
009      
AR
040    __
$d ABA008 $a ABA008 $b cze
041    0_
$a eng
044    __
$a xxk
100    1_
$a Bláha, Luděk, $d 1972- $7 xx0084400 $u Institute of Botany, Academy of Sciences, Lidicka 25/27, CZ65720 Brno, Czech Republic.
245    10
$a Inhibition of gap-junctional intercellular communication and activation of mitogen-activated protein kinases by cyanobacterial extracts--indications of novel tumor-promoting cyanotoxins? $c L. Blaha, P. Babica, K. Hilscherova, B.L. Upham
520    9_
$a Toxicity and liver tumor promotion of cyanotoxins microcystins have been extensively studied. However, recent studies document that other metabolites present in the complex cyanobacterial water blooms may also have adverse health effects. In this study we used rat liver epithelial stem-like cells (WB-F344) to examine the effects of cyanobacterial extracts on two established markers of tumor promotion, inhibition of gap-junctional intercellular communication (GJIC) and activation of mitogen-activated protein kinases (MAPKs) - ERK1/2. Extracts of cyanobacteria (laboratory cultures of Microcystis aeruginosa and Aphanizomenon flos-aquae and water blooms dominated by these species) inhibited GJIC and activated MAPKs in a dose-dependent manner (effective concentrations ranging 0.5-5mgd.w./mL). Effects were independent of the microcystin content and the strongest responses were elicited by the extracts of Aphanizomenon sp. Neither pure microcystin-LR nor cylindrospermopsin inhibited GJIC or activated MAPKs. Modulations of GJIC and MAPKs appeared to be specific to cyanobacterial extracts since extracts from green alga Chlamydomonas reinhardtii, heterotrophic bacterium Klebsiella terrigena, and isolated bacterial lipopolysaccharides had no comparable effects. Our study provides the first evidence on the existence of unknown cyanobacterial toxic metabolites that affect in vitro biomarkers of tumor promotion, i.e. inhibition of GJIC and activation of MAPKs.
536    __
$c Grant Number: R01 ES013268-01A2 (United States NIEHS NIH HHS)
536    __
$c Grant Number: R01 ES013268-01A2 (United States NIEHS NIH HHS)
590    __
$a bohemika - dle Pubmed
650    02
$a zvířata $7 D000818
650    02
$a Aphanizomenon $x chemie $x izolace a purifikace $7 D046890
650    02
$a karcinogeny $x chemie $x toxicita $7 D002273
650    02
$a mezibuněčná komunikace $x účinky léků $7 D002450
650    02
$a buněčné linie $7 D002460
650    02
$a komplexní směsi $x chemie $x toxicita $7 D045424
650    02
$a sinice $x chemie $x izolace a purifikace $7 D000458
650    02
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    02
$a aktivace enzymů $x účinky léků $7 D004789
650    02
$a extracelulárním signálem regulované MAP kinasy $x metabolismus $7 D048049
650    02
$a sladká voda $x mikrobiologie $7 D005618
650    02
$a mezerový spoj $x účinky léků $7 D017629
650    02
$a mikrocystiny $x analýza $x chemie $x izolace a purifikace $x toxicita $7 D052998
650    02
$a mitogenem aktivované proteinkinasy $x metabolismus $7 D020928
650    02
$a fosforylace $x účinky léků $7 D010766
650    02
$a krysa rodu Rattus $7 D051381
650    02
$a časové faktory $7 D013997
650    02
$a uracil $x analogy a deriváty $x toxicita $7 D014498
651    _2
$a Česká republika $7 D018153
655    _2
$a srovnávací studie $7 D003160
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Babica, Pavel, $d 1978- $7 xx0084399
700    1_
$a Hilscherová, Klára $7 xx0074007
700    1_
$a Upham, B. L.
773    0_
$t Toxicon $p Toxicon $g Roč. 55, č. 1 (2010), s. 126-134 $x def $w MED00004539
773    0_
$p Toxicon $g 55(1):126-34, 2010 Jan
910    __
$a ABA008 $b x $y 4
990    __
$a 20120319150917 $b ABA008
991    __
$a 20121126122102 $b ABA008
999    __
$a ok $b bmc $g 902396 $s 766079
BAS    __
$a 3
BMC    __
$a 2010 $b 55 $c 1 $d 126-134 $i def $m Toxicon $x MED00004539
LZP    __
$a 2012-1Q10/jj

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...